Overseas holiday bookings are expected to soar if the Pfizer/BioNTech vaccine is approved by the federal government and made available to Australians in early 2021 as plummeting numbers of COVID-19 cases lead to a boom in bookings for domestic trips.
Jenny Wiggins writes on business, specialising in infrastructure, telecommunications and transport. Connect with Jenny on Twitter. Email Jenny at jwiggins@afr.com
Lucas Baird is a journalist based in The Australian Financial Review's Sydney office. Connect with Lucas on Twitter. Email Lucas at lucas.baird@afr.com
Sue Mitchell writes the fortnightly Window Shopping column for the Financial Review and has covered retailing for over 30 years. Connect with Sue on Twitter. Email Sue at smitchell2045@gmail.com
